Quercetin and sorafenib as a novel and effective couple in programmed cell death induction in human gliomas

Neurotoxicity Research

Volumn 26, Issue 1, 2014, Pages 64-77

  Jakubowicz Gil, Joanna ^a   Langner, Ewa ^b   Bądziul, Dorota ^a   Wertel, Iwona ^c   Rzeski, Wojciech ^a,b  

^a MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^c MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Apoptosis; Autophagy; Gliomas; Heat shock proteins; Quercetin; Sorafenib

Indexed keywords

BECLIN 1; CASPASE 3; CASPASE 9; CYTOCHROME C; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 72; QUERCETIN; SMALL INTERFERING RNA; SORAFENIB; ANTINEOPLASTIC AGENT; CARBANILAMIDE DERIVATIVE; HSPB1 PROTEIN, HUMAN; NICOTINAMIDE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; BRAIN MITOCHONDRION; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CELL MEMBRANE PERMEABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG SENSITIVITY; ENZYME ACTIVATION; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LIGHT CHAIN; MITOCHONDRIAL MEMBRANE; NERVE CELL NECROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; ASTROCYTOMA; CHEMICALLY INDUCED; DRUG COMBINATION; DRUG EFFECTS; GLIOMA; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NECROSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ASTROCYTOMA; AUTOPHAGY; CELL LINE, TUMOR; DRUG THERAPY, COMBINATION; GLIOBLASTOMA; GLIOMA; HSP27 HEAT-SHOCK PROTEINS; HSP72 HEAT-SHOCK PROTEINS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; NECROSIS; NIACINAMIDE; PHENYLUREA COMPOUNDS; QUERCETIN;

EID: 84903759132     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-013-9452-x     Document Type: Article

References (42)

1. Balasubramanian K, Schroit AJ (2003) Aminophospholipid asymmetry: a matter of life and death. Annu Rev Physiol 65:701-734 (Pubitemid 38249174)
2. Bradford MM (1976) A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
3. Braganhol E, Zamin LL, Canedo AD, Horn F, Tamajusuku AS, Wink MR, Salbego C, Battastini AM (2006) Antiproliferative effect of quercetin in the human U138MG glioma cell line. Anticancer Drugs 17:663-671 (Pubitemid 44265867)
4. Garcia-Arencibia M, Hochfeld WE, Toh PPC, Rubinsztein DC (2010) Autophagy, a guardian against neurodegeneration. Semin Cell Dev Biol 21:691-698
5. Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E, Kroemer G (2006) Heat shock proteins 27 and Hsp 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle 5:2592-2601 (Pubitemid 44785803)
6. Ghobrial IM, Witzig TE, Adjei A (2005) Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 5:178-194 (Pubitemid 40826487)
7. Graner MW, Cumming RI, Binger DD (2007) The heat shock response and chaperone/heat shock proteins in brain tumors: surface expression, release and possible immune consequences. J Neurosci 27:11214-11227 (Pubitemid 47621325)
8. Hahn O, Stadler W (2006) Sorafenib. Curr Opin Oncol 18:615-621 (Pubitemid 44427636)
9. Hosokawa N, Hirayoshi K, Kudo H, Takechi H, Aoike A, Kawai K, Nagata K (1992) Inhibition of the activation of heat shock factor in vivo and in vitro by flavonoids. Mol Cell Biol 12:3490-3498
10. Huang R, Chen XQ, Huang Y, Chen N, Zeng H (2010) The multikinase inhibitor sorafenib induces caspase-dependent apoptosis in PC-3 prostate cancer cells. Asian J Androl 12:5270-5534
11. Jakubowicz-Gil J, Langner E, Wertel I, Piersiak T, Rzeski W (2010) Temozolomide, quercetin and cell death in the MOGGCCM astrocytoma cell line. Chem Biol Interact 188:190-203
12. Jakubowicz-Gil J, Langner E, Rzeski W (2011) Kinetic studies of the effects of Temodal and quercetin on astrocytoma cells. Pharmacol Rep 63:403-416
13. Jakubowicz-Gil J, Langner E, Badziul D, Wertel I, Rzeski W (2013a) a) Apoptosis induction in human glioblastoma multiforme T98G cells upon temozolomide and quercetin treatment. Tumor Biol 34:2367-2378
14. Jakubowicz-Gil J, Langner E, Badziul D, Wertel I, Rzeski W (2013b) Silencing of Hsp27 and Hsp72 in glioma cells as a tool for programmed cell death induction upon temozolomide and quercetin treatment. Toxicol App Pharmacol. doi:10.1007/s13277-013-0785-0
15. Jankowska A, Skonieczna D, Rommerts FFC, Warchoł JB (1997) Investigations on apoptosis in Leydig cells cultured in vitro. Folia Histochem Cytobiol 35:97-98 (Pubitemid 27186574)
16. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y, Yoshimori T (2000) LC3 a mammalian homologue of yeast Apg8p is localized in autophagosome membranes after processing. EMBO J 19:5720-5728
17. Kim EJ, Choi CH, Park JK, Kang SK, Kim YK (2008) Underlying mechanism of quercetin - induced cell death in human glioma cells. Neurochem Res 33:971-979
18. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Canenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-225 (Pubitemid 34212595)
19. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
20. Lefranc F, Kiss R (2006) Autophagy, the Trojan horse to combat glioblastomas. Neurosurg Focus 20:E7
21. Lin CJ, Lee CC, Shih YL, Lin CH, Wang SH, Chen TH, Shih CM (2012) Inhibition of mitochondria and endoplasmic reticulum stress-mediated autophagy augments temozolomide-induced apoptosis in glioma cells. PLoS ONE 7:e38706
22. Lo HW (2010) Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas. Curr Cancer Drug Targets 10:840-848
23. Luo S, Rubinsztein DC (2010) Apoptosis blocks beclin 1-dependent autophagosome synthesis - an effect reduced by Bcl-xL. Cell Death Differ 17:268-277
24. Nabors LB, Supko JG, Rosenfeld M, Chamberlain M, Phuphanich S, Batchelor T, Desideri S, Ye X, Wright J, Gujar S, Grossman SA (2011) Phase I trial of sorafenib in patients with recurrent or progressive malignant glioma. Neur Oncol 13:1324-1330
25. Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64:479-489 (Pubitemid 40781150)
26. Omuro AM, Faivre S, Raymond E (2007) Lessons learned in the development of targeted therapy for malignant gliomas. Mol Cancer Ther 6:1909-1919 (Pubitemid 47052481)
27. Park MA, Mitchell C, Zhang G, Yacoub A, Allegood J, Häussinger D, Reinehr R, Larner A, Spiegel S, Fisher PB, Voelkel-Johnson C, Ogretmen B, Grant S, Dent P (2010) Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a Ca(2+) - de novo ceramide-PP2A-reactive oxygen species-dependent signaling pathway. Cancer Res 70:6313-6324
28. Pirtoli L, Cevenini G, Tini P, Vannini M, Oliveri G, Marsisli S, Mourmoruas V, Rubino G, Miracco C (2009) The prognostic role of beclin 1 protein expression in high-grade gliomas. Autophagy 5:930-936
29. Rahmani M, Davis EM, Crabtree TR, Habibi JR, Nguyen TK, Dent P, Grant S (2007) The kinase inhibitor sorafenib induces cell death through a process involving induction of endoplasmic reticulum stress. Mol Cell Biol 27:5499-5513 (Pubitemid 47124402)
30. Ramos S (2007) Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem 18:427-442
31. Russo GL (2007) Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem Pharmacol 33:533-544
32. Schültke E, Kamencic H, Zhao M, Tian GF, Baker AJ, Griebel RW, Juurlink BHJ (2005) Neuroprotection following fluid percussion brain trauma: a pilot study using quercetin. J Neurotrauma 22:1475-1484 (Pubitemid 43122361)
33. Sieglin MD, Raskett CM, Gilbert CA, Ross AH, Altieri DC (2010) Sorafenib exerts anti-glioma activity in vitro and in vivo. Neurosci Lett 478:165-170
34. Sreedhar AS, Csermley P (2007) Heat shock proteins in the regulation of apoptosis: new strategies in tumor therapy. A comprehensive review. Pharmacol Ther 101:227-257
35. Stetler RA, Gan Y, Zhang W, Liou AK, Gao Y, Cao G, Chen J (2010) Heat shock proteins: cellular and molecular mechanisms in the CNS. Prog Neurobiol 92:184-211
36. Takeuchi H, Kondo Y, Fujiwara K, Kanzawa T, Aoki H, Mills GB, Kondo S (2005) Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res 65:3336-3346 (Pubitemid 40524618)
37. Turturici G, Sconzo G, Geraci F (2011) Hsp70 and its molecular role in nervous system diseases. Biochem Res Int 2011:618127
38. Wang J (2008) Beclin 1 bridges autophagy, apoptosis and differentiation. Autophagy 4:947-948
39. Wilhelm SM, Carter C, Tang L, Wilkie D, McNabola A, Rong H, Chen C, Zhang X, Vincent P, McHugh M, Cao Y, Shujath J, Gawlak S, Eveleigh D, Rowley B, Liu L, Adnane L, Lynch M, Auclair L, Taylor I, Gedrich R, Voznesensky A, Riedl B, Post LE, Bollag G, Trail PA (2004) BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res 64:7099-7109 (Pubitemid 39331023)
40. Wirawan EVW, Vande Walle L, Kersse K, Cornelis S, Claerhout S, Vanoverberghe I, Roelandt R, De Rycke R, Verspurten J, Declerq W, Agostinis P, Vanden Berghe T, Lippens S, Vandenabeele P (2010) Caspase-mediated cleavage of beclin 1 inactivates beclin1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death Dis 1:e18
41. Yang F, Brown C, Buettner R, Hedvat M, Starr R, Scuto A, Schroeder A, Jensen MC, Jove R (2010) Sorafenib induces growth arrest and apoptosis of human glioblastoma cells via dephosphorylation of STAT3. Mol Cancer Ther 9:953-962
42. Yu C, Friday BB, Lai JP, Yang L, Sarkaria J, Kay NE, Carter CA, Roberts LR, Kaufmann SH, Adjei AA (2006) Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomob in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathway. Mol Cancer Ther 5:2378-2387 (Pubitemid 44530475)